Related Experiment Video
Updated: Aug 4, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
How often is occult atrial fibrillation in cryptogenic stroke causal vs. incidental? A meta-analysis
Napasri Chaisinanunkul1, Shaan Khurshid2, Brian H Buck3
1Department of Neurology, Phyathai 1 Hospital, Bangkok, Thailand.
Insights
Occult atrial fibrillation (AF) is found in 14.9% of cryptogenic stroke patients. When detected, this occult AF is causal in 38.2% of cases, suggesting anticoagulation may prevent recurrent strokes.
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- Long-term cardiac monitoring reveals occult atrial fibrillation (AF) in cryptogenic stroke (CS) patients.
- Occult AF is also present in non-stroke individuals and known cause stroke (KS) patients.
- Estimating the causal vs. incidental nature of occult AF in CS is crucial for clinical management.
Approach:
- A systematic search identified case-control and cohort studies comparing long-term monitoring in CS and KS patients.
- A random-effects meta-analysis estimated the differential frequency of occult AF in CS versus KS.
- Bayes' theorem was applied to calculate the probability of occult AF being causal in CS.
Key Points:
- Three studies with 560 patients (315 CS, 245 KS) were analyzed.
- The meta-analysis showed a higher odds of occult AF in CS (OR 1.80, p=0.03).
- Occult AF in CS patients is estimated to be causal in 38.2% of cases, with higher probability in younger patients.
Conclusions:
- Preliminary evidence suggests occult AF is causal in approximately 38.2% of cryptogenic stroke cases.
- These findings support the potential benefit of anticoagulation therapy for preventing recurrent strokes in CS patients with occult AF.
Introduction:
Long-term cardiac monitoring studies have unveiled low-burden, occult atrial fibrillation (AF) in some patients with otherwise cryptogenic stroke (CS), but occult AF is also found in some individuals without a stroke history and in patients with stroke of a known cause (KS). Clinical management would be aided by estimates of how often occult AF in a patient with CS is causal vs. incidental.
Methods:
Through a systematic search, we identified all case-control and cohort studies applying identical long-term monitoring techniques to both patients with CS and KS. We performed a random-effects meta-analysis across these studies to determine the best estimate of the differential frequency of occult AF in CS and KS among all patients and across age subgroups. We then applied Bayes' theorem to determine the probability that occult AF is causal or incidental.
Results:
The systematic search identified three case-control and cohort studies enrolling 560 patients (315 CS, 245 KS). Methods of long-term monitoring were implantable loop recorder in 31.0%, extended external monitoring in 67.9%, and both in 1.2%. Crude cumulative rates of AF detection were CS 47/315 (14.9%) vs. KS 23/246 (9.3%). In the formal meta-analysis, the summary odds ratio for occult AF in CS vs. KS in all patients was 1.80 (95% CI, 1.05-3.07), p = 0.03. With the application of Bayes' theorem, the corresponding probabilities indicated that, when present, occult AF in patients with CS is causal in 38.2% (95% CI, 0-63.6%) of patients. Analyses stratified by age suggested that detected occult AF in patients with CS was causal in 62.3% (95 CI, 0-87.1%) of patients under the age of 65 years and 28.5% (95 CI, 0-63.7%) of patients aged 65 years and older but estimates had limited precision.
Conclusion:
Current evidence is preliminary, but it indicates that in cryptogenic stroke when occult AF is found, it is causal in about 38.2% of patients. These findings suggest that anticoagulation therapy may be beneficial to prevent recurrent stroke in a substantial proportion of patients with CS found to have occult AF.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

